Drake, Pascal M W <br/><br/>
Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?  [electronic resource] 

 -  British journal of clinical pharmacology  01 2017 
 - 82-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/bcp.13041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Biological Products--standards<br/>Biotechnology--legislation & jurisprudence<br/>Dietary Supplements--standards<br/>Drug Labeling<br/>Legislation, Drug<br/>Molecular Farming--legislation & jurisprudence<br/>Plants, Genetically Modified<br/>Recombinant Proteins--biosynthesis